DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Credit Suisse Maintains Outperform on Entasis Therapeutics Hldg, Lowers Price Target to $14

Credit Suisse maintains Entasis Therapeutics Hldg (NASDAQ:ETTX) with a Outperform and lowers the price target from $18 to $14.

Benzinga · 03/12/2020 14:05

Credit Suisse maintains Entasis Therapeutics Hldg (NASDAQ:ETTX) with a Outperform and lowers the price target from $18 to $14.